WO2002048361A3 - Nouvelles proteines secretees et leurs utilisations - Google Patents

Nouvelles proteines secretees et leurs utilisations Download PDF

Info

Publication number
WO2002048361A3
WO2002048361A3 PCT/US2001/043174 US0143174W WO0248361A3 WO 2002048361 A3 WO2002048361 A3 WO 2002048361A3 US 0143174 W US0143174 W US 0143174W WO 0248361 A3 WO0248361 A3 WO 0248361A3
Authority
WO
WIPO (PCT)
Prior art keywords
secreted proteins
novel secreted
useful
novel
proteins
Prior art date
Application number
PCT/US2001/043174
Other languages
English (en)
Other versions
WO2002048361A2 (fr
Inventor
Margret Barbara Basinski
Radmila Micanovic
Bradley Jay Mills
Patanjali Raghavac Sankhavaram
Eric Wen Su
Sheng-Hung Rainbow Tschang
Gabor Varga
He Wang
Original Assignee
Lilly Co Eli
Margret Barbara Basinski
Radmila Micanovic
Bradley Jay Mills
Patanjali Raghavac Sankhavaram
Eric Wen Su
Sheng-Hung Rainbow Tschang
Gabor Varga
He Wang
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli, Margret Barbara Basinski, Radmila Micanovic, Bradley Jay Mills, Patanjali Raghavac Sankhavaram, Eric Wen Su, Sheng-Hung Rainbow Tschang, Gabor Varga, He Wang filed Critical Lilly Co Eli
Priority to AU2002236440A priority Critical patent/AU2002236440A1/en
Priority to EP01985964A priority patent/EP1399474A2/fr
Publication of WO2002048361A2 publication Critical patent/WO2002048361A2/fr
Publication of WO2002048361A3 publication Critical patent/WO2002048361A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

La présente invention concerne des séquences d'acides nucléiques codant de nouvelles protéines humaines. On utilise ces nouveaux acides nucléiques pour élaborer les cellules hôtes et vecteurs d'ADN revendiqués de cette invention et pour préparer les anticorps et protéines revendiqués recombinants utilisés dans les applications médicales et méthodes revendiquées.
PCT/US2001/043174 2000-12-15 2001-12-04 Nouvelles proteines secretees et leurs utilisations WO2002048361A2 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AU2002236440A AU2002236440A1 (en) 2000-12-15 2001-12-04 Novel secreted proteins and their uses
EP01985964A EP1399474A2 (fr) 2000-12-15 2001-12-04 Nouvelles proteines secretees et leurs utilisations

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25585000P 2000-12-15 2000-12-15
US60/255,850 2000-12-15

Publications (2)

Publication Number Publication Date
WO2002048361A2 WO2002048361A2 (fr) 2002-06-20
WO2002048361A3 true WO2002048361A3 (fr) 2003-12-24

Family

ID=22970116

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/043174 WO2002048361A2 (fr) 2000-12-15 2001-12-04 Nouvelles proteines secretees et leurs utilisations

Country Status (3)

Country Link
EP (1) EP1399474A2 (fr)
AU (1) AU2002236440A1 (fr)
WO (1) WO2002048361A2 (fr)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8008332B2 (en) 2006-05-31 2011-08-30 Takeda San Diego, Inc. Substituted indazoles as glucokinase activators
US8034822B2 (en) 2006-03-08 2011-10-11 Takeda San Diego, Inc. Glucokinase activators
US8124617B2 (en) 2005-09-01 2012-02-28 Takeda San Diego, Inc. Imidazopyridine compounds
US8163779B2 (en) 2006-12-20 2012-04-24 Takeda San Diego, Inc. Glucokinase activators
US8173645B2 (en) 2007-03-21 2012-05-08 Takeda San Diego, Inc. Glucokinase activators

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001060850A1 (fr) * 2000-02-14 2001-08-23 Smithkline Beecham Corporation Nouveaux composes

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997007198A2 (fr) * 1995-08-11 1997-02-27 Genetics Institute, Inc. Sequences d'adn et proteines secretees codees par celles-ci

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1385954A2 (fr) * 2000-12-14 2004-02-04 Incyte Genomics, Inc. Proteines associees a la croissance, a la differenciation et a la mort cellulaire

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997007198A2 (fr) * 1995-08-11 1997-02-27 Genetics Institute, Inc. Sequences d'adn et proteines secretees codees par celles-ci

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL [online] EBI, Hinxton UK; 21 June 2000 (2000-06-21), "Homo sapiens chromosome 19 clone CTD-2527I21, WORKING DRAFT SEQUENCE, 39 unordered pieces.", XP002215015, Database accession no. AC020907 *
DATABASE EMBL [online] EBI, Hinxton UK; 31 October 2001 (2001-10-31), "603176686F1 NIH_MGC_121 Homo sapiens cDNA clone IMAGE:5240997 5', mRNA sequence.", XP002214928, Database accession no. BI918512 *
DATABASE EMBL [online] EBI, Hinxton, UK; 1 September 1999 (1999-09-01), "wt51e04.x1 NCI_CGAP_Pan1 Homo sapiens cDNA clone IMAGE:2511006 3', mRNA sequence.", XP002215556, Database accession no. AI983848 *
KLEIN R D ET AL: "SELECTION FOR GENES ENCODING SECRETED PROTEINS AND RECEPTORS", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE. WASHINGTON, US, vol. 93, no. 14, 9 July 1996 (1996-07-09), pages 7108 - 7113, XP002061411, ISSN: 0027-8424 *
SCHEEL HARTMUT ET AL: "A common protein interaction domain links two recently identified epilepsy genes.", HUMAN MOLECULAR GENETICS, vol. 11, no. 15, 2002, 15 July, 2002, pages 1757 - 1762, XP002214927, ISSN: 0964-6906 *
See also references of EP1399474A2 *
SOMERVILLE ROBERT P T ET AL: "Identification of the promoter, genomic structure, and mouse ortholog of LGI1.", MAMMALIAN GENOME, vol. 11, no. 8, August 2000 (2000-08-01), pages 622 - 627, XP002214926, ISSN: 0938-8990 *
YOKOYAMA-KOBAYASHI M ET AL: "A signal sequence detection system using secreted protease activity as an indicator", GENE, ELSEVIER BIOMEDICAL PRESS. AMSTERDAM, NL, vol. 163, no. 2, 3 October 1995 (1995-10-03), pages 193 - 196, XP004041983, ISSN: 0378-1119 *

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8124617B2 (en) 2005-09-01 2012-02-28 Takeda San Diego, Inc. Imidazopyridine compounds
US8034822B2 (en) 2006-03-08 2011-10-11 Takeda San Diego, Inc. Glucokinase activators
US8008332B2 (en) 2006-05-31 2011-08-30 Takeda San Diego, Inc. Substituted indazoles as glucokinase activators
US8394843B2 (en) 2006-05-31 2013-03-12 Takeda California, Inc. Substituted isoindoles as glucokinase activators
US8163779B2 (en) 2006-12-20 2012-04-24 Takeda San Diego, Inc. Glucokinase activators
US8173645B2 (en) 2007-03-21 2012-05-08 Takeda San Diego, Inc. Glucokinase activators

Also Published As

Publication number Publication date
WO2002048361A2 (fr) 2002-06-20
EP1399474A2 (fr) 2004-03-24
AU2002236440A1 (en) 2002-06-24

Similar Documents

Publication Publication Date Title
WO2002014358A3 (fr) Nouvelles proteines secretees et leurs utilisations
WO2002008277A3 (fr) Acides nucleiques, vecteurs, cellules hotes, polypeptides et leurs utilisations
WO1999031236A3 (fr) ADNc PROLONGES POUR PROTEINES SECRETEES
WO1999025825A3 (fr) ADNc ETENDUS POUR PROTEINES SECRETEES
WO2001000806A3 (fr) Proteines codant des adn complementaires avec des peptides-signal
WO2002032939A3 (fr) Nouvelles proteines secretees et leurs utilisations
WO2001087978A3 (fr) La 38594, nouveau transporteur humain et ses utilisations
WO2002026801A3 (fr) Nouvelles proteines secretees et utilisations de ces dernieres
WO2002048361A3 (fr) Nouvelles proteines secretees et leurs utilisations
WO2002016578A3 (fr) Nouvelles proteines secretees et procedes d'utilisation de ces dernieres
WO2001092493A3 (fr) Nouvelles aminopeptidases humaines 21956 et 25856, et utilisations
WO2002012475A3 (fr) Facteur associe a c1q, polypeptides homologues et utilisations therapeutiques associees
EP1529843A3 (fr) Protéines sécrétées et leurs utilisations
WO2003029778A3 (fr) Proteines secretees et utilisations associees
WO2003083048A3 (fr) Nouvelles proteines secretees et leurs utilisations
WO2004013281A3 (fr) Nouvelles proteines et leurs utilisations
WO2002000709A3 (fr) Polypeptides homologues de la cerebelline et utilisations therapeutiques de ces polypeptides
WO2001075076A3 (fr) 33167, nouvelle hydrolase humaine, et utilisations associees
WO2004044126A3 (fr) Nouvelles proteines et leurs utilisations
WO2002016579A8 (fr) Acides nucleiques, vecteurs, cellules hotes, polypeptides et utilisations de ces derniers
WO2002029042A3 (fr) Molecules 48120, 23479, et 46689, nouvelles hydrolases humaines et leurs applications
EP1225182A3 (fr) Transporteur phospholipidique humain
WO2003035840A3 (fr) 69583 et 85924, nouveaux membres d'une famille de proteine kinase humaine et utilisations associees
WO2002026802A3 (fr) M32404, nouvelle trypsine humaine et utilisations de celle-ci
WO2002059314A3 (fr) 52020, nouvel antigene associe a un melanome humain et ses utilisations

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ CZ DE DE DK DK DM DZ EC EE EE ES FI FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2001985964

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWP Wipo information: published in national office

Ref document number: 2001985964

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 2001985964

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP